The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 24,011 | 10,940 | 56,639 | 3,239 |
| Depreciation and amortization | 67,062 | 55,323 | 49,181 | 83,055 |
| Other amortization | 8,927 | 8,887 | 9,540 | 19,213 |
| Deferred rent | -780 | -793 | -730 | -1,556 |
| Stock based compensation | 4,858 | 5,451 | 3,429 | 5,741 |
| Loss on dispositions of real estate investments, net | 0 | -621 | 691 | -3,035 |
| Impairment of real estate investments | 418 | 11,802 | 3,768 | 34,365 |
| Impairment of intangible assets | - | 0 | - | - |
| (income) loss from unconsolidated entities | 792 | 657 | 462 | -3,086 |
| Distributions of earnings from unconsolidated entities | 3 | 211 | - | - |
| Deferred income tax benefit | -724 | -1,538 | -21,401 | - |
| Gain on re-measurement of previously held equity interests | - | 0 | 14,580 | - |
| Foreign currency gain (loss) | -810 | 25 | -978 | 4,172 |
| Loss on extinguishments of debt | 0 | -46 | -30 | -1,754 |
| Change in fair value of derivative financial instruments | 1,527 | 179 | 166 | -1,379 |
| Accounts and other receivables | 31,450 | 17,210 | -17,741 | 13,581 |
| Other assets | 7,176 | 14,742 | 887 | 5,006 |
| Accounts payable and accrued liabilities | 24,579 | 1,434 | 10,844 | 16,735 |
| Operating lease liabilities | 7,024 | 7,245 | 7,270 | 15,523 |
| Security deposits, prepaid rent and other liabilities | 128 | -2,839 | -1,222 | -327 |
| Net cash provided by operating activities | 81,067 | 55,165 | 107,185 | 132,091 |
| Developments and capital expenditures | 38,317 | 48,133 | 32,352 | 48,077 |
| Acquisitions of real estate investments | 165,937 | 544,024 | 258,515 | 81,886 |
| Proceeds from dispositions of real estate investments | 0 | 3,631 | 10,154 | 36,428 |
| Acquisitions of previously held equity interests | - | 118,398 | - | - |
| Investments in unconsolidated entities | 16 | 0 | 83 | 360 |
| Distributions in excess of earnings from unconsolidated entity | - | 0 | - | - |
| Issuances of real estate notes receivable | 0 | 0 | 0 | 5,855 |
| Principal repayments on real estate notes receivable | 0 | 1,163 | 3,000 | 6,625 |
| Real estate and other deposits | 164 | 4,212 | 661 | 1,737 |
| Proceeds from insurance recoveries | 1,343 | - | - | - |
| Net cash used in investing activities | -203,091 | -709,973 | -278,457 | -94,862 |
| Borrowings under mortgage loans payable | 0 | 0 | 0 | 30,000 |
| Payments on mortgage loans payable | 5,520 | 5,447 | 13,004 | 30,708 |
| Redemptions of noncontrolling interests | - | 0 | 0 | 0 |
| Borrowings under the lines of credit and term loan | 0 | 33,500 | 82,500 | 132,500 |
| Repurchase of common stock | - | 0 | 0 | 0 |
| Payments on the lines of credit and term loan | 0 | 33,500 | 82,500 | 271,532 |
| Purchase of noncontrolling interests | - | 0 | 0 | 0 |
| Borrowings under financing obligations | - | 0 | - | - |
| Payments on financing and other obligations | 351 | 352 | 349 | 1,049 |
| Deferred financing costs | 6 | 254 | 0 | 259 |
| Debt extinguishment costs | 0 | 46 | 52 | 52 |
| Proceeds from issuance of common stock in offerings | 191,552 | 676,697 | 243,276 | 236,300 |
| Proceeds from issuance of common stock pursuant to employee stock purchase plan | 135 | 0 | 238 | - |
| Payment of offering costs | 1,347 | 5,320 | 2,424 | 2,313 |
| Distributions paid | 46,822 | 42,856 | 41,241 | 79,425 |
| Payments to taxing authorities in connection with common stock directly withheld from employees | 9,708 | 0 | 0 | 2,402 |
| Distributions to noncontrolling interests | 591 | 613 | 602 | 1,214 |
| Security deposits, net | -146 | 393 | -151 | -498 |
| Net cash provided by (used in) financing activities | 127,196 | 622,202 | 185,691 | 9,348 |
| Net change in cash, cash equivalents and restricted cash | 5,172 | -32,606 | 14,419 | 46,577 |
| Effect of foreign currency translation on cash, cash equivalents and restricted cash | - | -4 | 66 | - |
| Cash, cash equivalents and restricted cash beginning of period | - | 184,363 | 123,301 | - |
| Cash, cash equivalents and restricted cash end of period | - | 151,753 | 184,363 | - |
American Healthcare REIT, Inc. (AHR)
American Healthcare REIT, Inc. (AHR)